Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Travere Therapeutics, Inc.
TVTX
Revenue recognized that was included in deferred income at the beginning of the period
Revenue recognized that was included in deferred income at the beginning of the period at other companies
Paycom Software
PAYC
$9M
-5.3%
Ondas, Inc.
ONDS
$2.2M
+18,233%
Churchill Downs
CHDN
$6M
0.0%
Constellium
CSTM
$12M
+9.1%
Allison Transmission Holdings
ALSN
$17M
+54.5%
Baxter International
BAX
$46M
+35.3%
Segments
By product
See full
License and collaboration revenue
$2.87M
-50.9%
Other financials
Income statement
See full
Revenue
$127.2M
+55.6%
Gross profit
$125.2M
+62.5%
Operating income
-$36.9M
+13.5%
Net income
-$37.1M
+10.0%
EPS (diluted)
-$0.40
+14.9%
Balance sheet
See full
Cash & equivalents
$78.4M
+26.6%
Total debt
$15.6M
-82.6%
Total equity
$98.7M
+201%
Total assets
$555.2M
+1.2%
Cash flow
See full
Operating cash flow
-$40.4M
+4.3%
CapEx
$140.0K
—
Free cash flow
-$42.5M
+28.1%
Valuation
See full
Market cap
$5.13B
+72.3%
Enterprise value
$5.07B
+65.5%
P/S
9.6×
-1.3×
Profitability
See full
Gross margin
98.6%
+2.6pp
Operating margin
-10.6%
-5.0pp
Net margin
-20.3%
-9.5pp
FCF margin
-133.9%
-34.4pp
Returns & leverage
See full
Return on equity
-706%
-1,302pp
Debt / equity
0.2×
-2.6×
Current ratio
3.1×
+1.1×